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Cytochrome bd is a terminal quinol oxidase in Escherichia coli.Mitochondrial respiration is inhibited
at cytochrome bc1 (complex III) by myxothiazol. Mixing puriﬁed cytochrome bd oxidase with myx-
othiazol-inhibited bovine heart submitochondrial particles (SMP) restores up to 50% of the original
rotenone-sensitive NADH oxidase and succinate oxidase activities in the absence of exogenous ubi-
quinone analogs. Complex III bypassed respiration and is saturated at amounts of added cytochrome
bd similar to that of other natural respiratory components in SMP. The cytochrome bd tightly binds
to the mitochondrial membrane and operates as an intrinsic component of the chimeric respiratory
chain.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction not impossible to dissect catalytic activities of the individualMembranous quinone-reactive proteins are key components of
diverse respiratory and photosynthetic electron transfer chains in
both prokaryotic and eukaryotic organisms. The quinone/quinol
(Q) oxidoreduction at speciﬁc quinone-reactive sites (Q-sites) in
several cases is coupled with the generation of proton-motive force
across the coupling membrane. Extremely hydrophobic natural
quinones with 6–10 isoprenoid units also function as a mobile
membranous redox pool (buffer) in carrying reducing equivalents
between the respiratory chain components [1]. In situ studies on
enzymology of quinone oxidoreduction are greatly hampered by
quantitative limitation of the endogenous substrate/product.
When complete coupled or uncoupled NADH or succinate oxidase
activities are measured complexes III and IV operate synchro-
nously with the quinone reductases thus making it difﬁcult, ifchemical Societies. Published by E
chemistry, School of Biology,
Federation. Fax: +7 495 939
ogradov).complexes. Thus, several water-soluble synthetic quinone homo-
logs and/or analogs are commonly used for kinetic assays of
individual quinone-reactive complexes [2]. Although this approach
is useful, it still suffers from a number of limitations. When low
concentrations of a Q-type acceptor/donor are used an enzyme
does not operate at its maximal turnover and the true initial rate
is hard to detect because of accumulation of the reaction product
which may act as an inhibitor. For example, this kinetic behavior
has been documented for the succinate:ubiquinone reductase
reaction catalyzed by complex II [3,4]. When high concentrations
of the water-soluble artiﬁcial Q-type acceptors are used as
substrate the reaction with other than the natural Q-site associated
redox components becomes signiﬁcant, as exempliﬁed by the
loss of rotenone-sensitivity of the NADH:ubiquinone oxidoreduc-
tase reaction catalyzed by complex I at high concentrations of Q1
[5].
Our long-standing interest in the operation of Q-site(s) in
mitochondrial membrane-bound NADH and succinate quinone
reductases has prompted us to develop reliable assay procedures
suitable for studies on steady-state quinone reduction free of those
limitations. To achieve this goal we decided to use the puriﬁedlsevier B.V. All rights reserved.
Table 1
Effects of bd quinol oxidase on energy transduction by coupled SMP.
lmol/min per mg of SMP proteina
 Uncoupler + Uncouplerb RCRc
NADH oxidase
1. SMP (control) 0.30 1.5 5.0
2. SMP + QOd 0.5 1.3 2.6
3. As before + 0.5 lM myxothiazol 0.4 0.5 1.2
NADH:Q1-reductase
e
4. SMP 0.4 1.0 2.5
5. SMP + QOd 0.5 0.8 1.6
a All the activities were measured in the presence of bovine serum albumin
(1 mg/ml) in the standard reaction mixture supplemented by 0.1 mM NADH.
b Gramicidin D (0.2 lg/ml); respiration rate measured after addition of uncoupler
to the same assay sample as depicted in previous column.
c Respiratory control ratio.
d The assembled system was prepared as described in Fig. 3; the content of bd
quinol oxidase (QO) added to the reconstitution mixture was 0.15 nmol per mg of
SMP protein.
e The initial rates of 80 lM Q1 reduction were measured in the presence of
0.5 lM myxothiazol.
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coli [6] as a quinone-regenerating system in a continuous coupled
NADH:quinone reductase–quinol oxidase assay. We assumed that
complex I, in coupled or uncoupled submitochondrial particles
and admittedly uncoupled soluble cytochrome bd quinol oxidase,
will operate independently being kinetically connected by exoge-
nously added water-soluble quinone. An expected advantage of
this approach is that in such a system steady-state complex I oper-
ation could be measured at any level of quinone reduction that
could be reached by unrestricted variation of relative contents of
submitochondrial particles (SMP), quinol oxidase, and total con-
centration of Q1 in the assay samples. Although this coupled assay
was, indeed, operative in the presence of limited amounts of Q1
and ‘‘kinetic excess” of quinol oxidase, we found, unexpectedly,
that the system was also operative in the absence of any externally
added quinones, thus suggesting that endogenous membrane-
bound Q10 is accessible to the bacterial quinol oxidase. This report
describes some properties of the chimeric respiratory chain assem-
bled from bovine heart SMP and bacterial cytochrome bd quinol
oxidase.Fig. 1. NADH oxidation by complex III-inhibited submitochondrial particles in the
presence of the bacterial quinol oxidase and water-soluble quinone (Q1). The
standard reaction mixture (see Section 2) was supplemented by gramicidin D
(0.1 lg/ml). The SMP protein content in all assays was 5 lg/ml; the ﬁnal
concentrations of other addition were: NADH, 0.1 mM; rotenone (Rot), 5 lM; and
Q1, 3 lM. (A) Control, no myxothiazol and Q1were added and (B) 0.5 lM
myxothiazol, 5 lM Q1, and cytochrome bd quinol oxidase (1 lg protein/ml)
preincubated in the assay mixture for 7 min were present.2. Materials and methods
Inside-out bovine heart SMP were prepared [7], treated with
oligomycin, and their NADH and succinate dehydrogenase were
activated as described [8]. The cytochrome bd terminal quinol oxi-
dase of E. coli (strain GO105/pTK1) was prepared as described [9].
The ﬁnal preparation (2 mg/ml) was dissolved in 50 mM potassium
phosphate buffer, pH 7.4, containing 5 mM EDTA and 0.05% N-lau-
roylsarcosine. The heme d content (10 nmol/mg of protein) was
estimated from the dithionite-reduced-minus-‘‘air-oxidized” spec-
tra assuming De628–607 = 10800 M1 cm1. All preparations were
stored in liquid nitrogen and thawed just before use. The standard
reaction mixture was comprised of 0.25 M sucrose, 50 mM Tris–
HCl (pH 7.7), and 0.2 mM EDTA. When appropriate, NADH
(0.1 mM), potassium succinate (20 mM), Q1H2, Q1 or Q2, and myx-
othiazol (0.5 lM) were added to the standard reaction mixture. All
assays were performed at 37 C. The NADH oxidase activity was
followed by the absorption decrease at 340 nm assuming
e340 = 6.22 mM1 cm1. Succinate oxidase activity was followed
as an absorption increase at 278 nm (fumarate formation) assum-
ing e278 = 0.3 mM1 cm1; the latter value was determined by the
addition of aliquots of sodium fumarate to the suspension of SMP
incubated in the standard reaction mixture in the assay cuvette.
The quinol oxidase activity was assayed as an absorption increase
at 278 nm with 0.02 mM Q1H2 prepared as described [10] assum-
ing e278 = 10.2 mM1 cm1. Respiration-driven electrogenic activ-
ity was estimated as oxonol VI (1.5 lM) response [11] following
the absorption change at 624 nmminus 602 nm. Other experimen-
tal details are indicated in the legends to the ﬁgures and Table 1.
We noted that the quinol oxidase activity of cytochrome bd with
Q1H2 as the substrate was low if the reaction was initiated by
the addition of the soluble enzyme to the assay mixture (ﬁnal con-
centration of N-lauroylsarcosine originated from the stock solution
in the assay mixture was no more than 1  104%). The activity
gradually increased upon incubation of the diluted protein and
reached a maximum (10 lmol of Q1H2 oxidized per min per mg
of protein at 20 lM Q1H2) after about 7 min of preincubation. This
activation may be related to the similar behavior of cytochrome bd
from Azotobacter vinelandii observed by Jünemann and Rich [12], or
more likely, due to a structural rearrangement of the protein
caused by detergent dilution. This phenomenon was not further
examined, and the quinol oxidase activity assays were measured
after 7 min preincubation of the diluted enzyme in the standard as-
say mixture.Protein content was determined by the biuret procedure (SMP)
or by the Lowry method (quinol oxidase). All ﬁne chemicals were
from Sigma–Aldrich (USA).
3. Results
Fig. 1 demonstrates the tracings of NADH oxidation by control
(A) and myxothiazol-inhibited (B) SMP. When SMP were treated
with excess of the complex III inhibitor myxothiazol their uncou-
pled NADH and succinate oxidase (not shown) activities decreased
to less than 1% of the original (1.1 ± 0.3 and 0.8 ± 0.2 lmol per min
per mg of SMP protein, at 37 C, respectively) activities. If cyto-
chrome bd quinol oxidase and a limited amount of the water-solu-
ble ubiquinol homolog, Q1 were present in the assay mixture
(Fig. 1B) the rotenone-sensitive NADH oxidation was restored, as
expected.
When myxothiazol-treated SMP were added to the assay mix-
ture containing cytochrome bd quinol oxidase of E. coli and no
exogenous quinone their rotenone-sensitive NADH oxidase activity
Fig. 3. Myxothiazol-insensitive NADH (d) and succinate (s) oxidase of SMP as a
function of quinol oxidase in the assembling mixture. SMP (2 mg/ml) and different
amounts of quinol oxidase were incubated in the standard reaction mixture for
7 min at 20 C and the samples were placed in ice. The reactions were initiated by
addition of proper amounts of the mixture (20 lg of SMP protein/ml) to the assay
medium supplemented by gramicidin D, 0.2 lg/ml; NADH, 0.1 mM, or succinate,
20 mM; myxothiazol, 0.5 lM, and bovine serum albumin, 1 mg/ml. The speciﬁc
NADH and succinate oxidase activities of SMP in the absence of myxothiazol were
1.0 and 0.9 lmol per min per mg of SMP protein, respectively. When exogenous Q1
(7 lM) or Q2 (3 lM) were added to the mixture for the assays of NADH oxidase or
succinate oxidase, respectively, at saturating amount of quinol oxidase (0.3 nmol
per mg of SMP protein) both NADH and succinate oxidase activities were increased
up to 85% and 90% of the original (with no myxothiazol) level, respectively.
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vel (Fig. 2A). Neither thermally inactivated quinol oxidase (5 min at
100 C) nor the addition of an equivalent amount of the buffer con-
taining detergent in which the enzyme was solubilized reactivated
the myxothiazol-inhibited NADH oxidase. Qualitatively the same
phenomenon as shown in Fig. 2A (lag-phase with t1/2 of about
2 min) was seen when the succinate oxidase activity was assayed
(not shown). It could be suggested that the bacterial quinol oxidase
interacts with the SMP reduced ubiquinol pool by simple collision
and if so, the rate of NADH oxidase reactivation would be depen-
dent on both SMP and cytochrome bd content in the assay mixture.
This was not the case and the reactivation proceeded as the ﬁrst-
order time course with the rate constant of 0.4 min1 that was
independent of the quinol oxidase amount (Fig. 2B). This behavior
is expected if cytochrome bd rapidly binds to SMP and a slow intra-
molecular rearrangement (conformational change) of the bound
enzyme results in formation of a ubiquinol pool-reactive quinol
oxidase.
Fig. 3 shows the titration of the NADH and succinate oxidase
activities by the added quinol oxidase under conditions where
the myxothiazol-inhibited SMP and cytochrome bd were admixed
in a relatively concentrated preincubation mixture. The activities
were then determined after the mixtures were diluted into the as-
say cuvette. The titration pattern corresponds to the formation of a
tight (stoichiometric) complex between SMP and cytochrome bd
where the latter serves as an alternative myxothiazol-insensitive
quinol oxidase. Both myxothiazol-insensitive NADH and succinate
oxidase activities were saturated at a concentration of bd cyto-
chrome in the preincubation mixture of about 0.15 nmol/mg of
SMP protein.
Further support for assembly of a chimeric respiratory chain
was obtained when the preincubated mixture of SMP and cyto-
chrome bd was subjected to ultracentrifugation followed by wash-
ing (Fig. 4). An increase of the NADH oxidase activity of SMP (panel
A) paralleled the appearance of quinol oxidase activity in SMP and
the disappearance of enzyme activity from the supernatant (panel
B). Interestingly, preincubation of quinol oxidase in the presence of
SMP (binding of the soluble enzyme to the mitochondrial mem-
brane) resulted in a 10-fold increase of its Q1H2 oxidase activity
(panel B, second and third bars from the left).Fig. 2. The time course of bd quinol oxidase-induced myxothiazol-insensitive NADH oxi
preincubated in the standard reaction mixture for 7 min, myxothiazol (0.5 lM), gramicid
by the addition of SMP (20 lg/ml). (B) Semilogrithmic plot for the activation process assa
(N), and 2.5 (4) lg/ml. Amax and At, the speciﬁc activities at t?1 and particular tim
dependent on the amount of quinol oxidase was taken as the speciﬁc activity at t?1.It seemed improbable that true transmembraneous and prop-
erly oriented incorporation of cytochrome bd quinol oxidase into
inner mitochondrial membrane could be achieved by simple mix-
ing of SMP and bacterial enzyme. Nevertheless we examined the
electrogenic activity (Du estimated as oxonol VI response) of cyto-
chrome bd bound to SMP. No response, was detected when 30 lM
Q1H2 and 3 mM dithiothreitol were added to oligomycin-treated
SMP, whereas a clear response was seen when respiration was ini-
tiated by the addition of NADH.dase activity of SMP in the absence of added Q1. (A) Quinol oxidase (2.5 lg/ml) was
in D (0.1 lg/ml) and NADH (0.1 mM) were then added and the reaction was started
yed as in (A) in the presence of quinol oxidase: 0.5 (d), 0.75 (s), 1.0 (j), 1.5 (h), 2.0
e t, respectively. The ﬁnal constant rates of NADH oxidation which were linearly
Fig. 4. Binding of the bacterial quinol oxidase to SMP. SMP (2 mg/ml) and quinol oxidase (QO, 30 lg/ml) were preincubated as described in Fig. 3 in 4 ml samples. The
samples were subjected to ultracentrifugation and the NADH (A) and Q1H2 (B) oxidase activities were assayed as described in Fig. 3 in the precipitated material (after washing
by 8 ml of buffer) and in the supernatants (after ﬁrst centrifugation). The concentration of Q1H2 in the quinol oxidase activity assays was 20 lM. The activities are expressed in
lmol of the substrate oxidized per min per ml of the incubation mixture.
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ratory activities by uncouplers. It was of interest to see whether
chimeric rotenone-sensitive, myxothiazol-insensitive NADH oxi-
dase retains its energy-transducing capacity. Table 1 shows the re-
sults of representative experiments on the effects of uncoupler
(gramicidin D) on the NADH oxidase and NADH:Q1-reductase
activities as inﬂuenced by the presence of cytochrome bd quinol
oxidase in SMP. When artiﬁcial branching pathways of ubiquinol
oxidation were induced by the bacterial enzyme (uncoupled ubi-
quinol oxidation) the respiratory control ratio decreased from 4.9
to 2.6 (samples 1 and 2, respectively). The stimulation of NADH
oxidase activity of the complex III-inhibited SMP assembled with
the quinol oxidase was lost (sample 3) thus indicating that cou-
pling sites 2 (complex III) and 3 (cytochrome c oxidase) of the
mammalian respiratory chain are the major contributors to the
respiratory control phenomenon during NADH oxidation. The ini-
tial rate of the external Q1 reduction (operation of complex I only)
was still stimulated by uncoupler (sample 4), although to a lower
degree than the complete respiratory chain activity. In the pres-
ence of the bacterial quinol oxidase the respiratory control ratio
with external Q1 as the substrate was decreased (sample 5).
4. Discussion
In this manuscript we demonstrate that complex III inhibitor-
insensitive NADH (and succinate) oxidase activity can be con-
structed by simply mixing of mammalian SMP with bacterial cyto-
chrome bd quinol oxidase. The kinetics of the assembly process
(Fig. 2) correspond to a model where soluble quinol oxidase rapidly
binds to some component(s) of the inner mitochondrial membrane
and a relatively slow (k = 0.4 min1) transformation (conforma-
tional change) of the bound enzyme into its endogenous Q10-reac-
tive form then occurs resulting in catalytically active NADH
(succinate) oxidase. Notably, the incorporation of the enzyme into
the membrane is accompanied by large (about 10-fold) increase of
its reactivity with exogenously added Q1H2 (Fig. 4).
The assembled system is resistant to strong dilution (Fig. 3) and
extensive washing as evidenced by centrifugation (Fig. 4). In other
words, the bound bacterial enzyme behaves as any other natural
intrinsic component of the respiratory chain. The titration data
(Fig. 3) show that complex III inhibitor-insensitive NADH and suc-
cinate oxidase activities are saturated at an amount of added qui-
nol oxidase of about 0.15 nmol per mg of SMP protein. This value isvery close to that reported for complex I and complex II contents in
bovine heart SMP (0.1 and 0.14 nmol per mg of SMP, respectively)
[13,14]. The ﬁnding that a foreign protein can complement func-
tion of a mitochondrial respiratory chain component is not unique.
It has been shown that the yeast Ndi1 enzyme can partially com-
plement for loss of function of complex I in mammalian mitochon-
dria [15,16]. Recently, uncoupled NADH oxidase activity have been
restored in engineered mouse mtDNA-less (q0) cells by transform-
ing them with the alternative quinol oxidase (Aox) of the ascomy-
cete Emiricella nidulans and the yeast single subunit NDi1 [17].
Two questions naturally arise: (i) what is the factor(s) that lim-
its binding of foreign proteins to the mitochondrial membrane?
and (ii) why the quinol-saturated myxothiazol-insensitive NADH
and succinate oxidase activities are still signiﬁcantly lower (about
50%) than those seen in the natural complex III-operative respira-
tory chain? Two possibilities relevant to (i) seem feasible. The sim-
plest explanation is that there exists not enough free surface area
on the inner mitochondrial membrane to accept foreign hydropho-
bic proteins and the apparent stoichiometry of binding is just a
coincidental phenomenon. More interesting, although a highly
speculative proposal is that evolutionary conserved speciﬁc pro-
tein–protein interactions between some subunits of the mamma-
lian complex I (and/or complex II) or other mitochondrial inner
membrane components are responsible for the ‘‘stoichiometric”
binding of bd cytochrome. This limitation in ‘‘proper” Q10-reactive
binding may also be an explanation of the lower NADH and succi-
nate oxidase activities of the chimeric respiratory chain as com-
pared to the natural system.
Incorporation of the bacterial enzyme into the native mamma-
lian respiratory chain results in apparent uncoupling (a decrease of
RCR, Table 1) presumably, because of at least partial abbreviation
of energy transduction at Site 2. When only the alternative quinol
oxidase operates in NADH oxidase (in the presence of myxothiazol,
Table 1, sample 3), no stimulation by the uncoupler is seen. A plau-
sible explanation for this lies in the limited capacity of the quinol
oxidase-mediated NADH oxidation. The rate of proton leakage un-
der these conditions may be comparable with decreased proton
translocating activity of complex I. Indeed, when NADH oxidation
rate was increased by the addition to the chimeric system of exog-
enous Q1 (Table 1, sample 5), the stimulation of NADH oxidation,
although not high became evident.
The last point to be brieﬂy discussed is the structural arrange-
ment of the bacterial quinol oxidase bound to the mitochondrial
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proton translocating quinone oxidases in the E. coli aerobic respira-
tory chain [6,18]. The enzyme contains two transmembrane sub-
units (subunit I, 58 kDa and subunit II, 43 kDa), and two b-type
and one d-type heme [19]. Trypsin and chymotrypsin digestion
experiments [20,21], ubiquinone azido homolog photoafﬁnity
labeling [22,23], and site-directed mutagenesis [24] suggest that
the natural Q8H2-reactive site is located near the N-terminal region
of subunit I (loops VI/VII) located in the bacterial periplasm [23]
and may be exposed to solvent. An amphipathic ‘‘ramp” guiding
the ubiquinone head group from the membrane domain into its
catalytic site located at a substantial distance from the membrane
surface has been proposed for the ubiquinone–N2 iron sulfur cen-
ter interaction in complex I [25]. Such a quinone guiding channel
may preexist or be formed by interaction with speciﬁc proteins
in the bacterial quinol oxidase bound to the mitochondrial
membrane.
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